Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02757508 · ClinicalTrials.gov registry record · NA
Healthy and Affordable Protein Rich Foods for African Market
A NA study of School Feeding Programs and Nutrition Supplements, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 1,041
- Enrollment target
- 2
- Study locations
NCT02757508: Completed NA study of School Feeding Programs and Nutrition Supplements, sponsored by Washington University School of Medicine.
NCT02757508 is a NA study of School Feeding Programs and Nutrition Supplements that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,041 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02757508, a NA study of School Feeding Programs and Nutrition Supplements, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,041 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is to gather information on school feeding programs and to measure the effect on linear growth and cognitive performance when providing a high-quality milk protein source or a combination of a high-quality milk protein source and rice proteins as a nutritional supplement to school children in Ghana. Children will receive a meal with a protein powder supplement with vitamins and minerals mixed into it. Participation is expected to last for 9 months. 1200 Children aged 6-7 years attending school will be enrolled throughout twenty primary schools (60 per school). Participants will be randomized to one of four groups: Control: Vitamins/minerals-200 mg premix contain the required micronutrients as per UNICEF recommendations. For groups 1-3 the same vitamin/mineral mix will be used along with Group 1. Vitamins/minerals + Milk Protein (8.75 g)-the milk protein is a skim milk powder with the sugar lactose. Group 2. Vitamins/minerals + Milk/plant Protein (8.75g)-the milk protein is a skim milk protein powder and the plant protein is a rice protein concentrate and the sugar lactose. Group 3. Vitamins/minerals + Milk Protein (4.38g)-the milk protein is a skim milk protein powder with the sugar lactose. At baseline measurements-weight,height,mid-upper arm circumference,and body composition will be taken, fasting blood spot test will be administered to measure levels of Insulin and insulin like growth factor and other metabolic test, and computer based cognitive testing. Demographic information will be collected along with a dietary survey. Primary outcomes are cognitive performance on standardized tests and change in height-for-age z-score over the supplementation period, 9 months total. Questionnaires will be administered to collect demographic data and dietary information. At the mid-point all measurements will be taken again and cognitive testing will be repeated. At the end of the study all measurements will be taken again, cognitive testing repeated, bloo
Primary Outcome
Five tests created by Cambridge Cognition (CANTAB) will be selected and administered at enrollment, halfway through the intervention, and at the end of the intervention. The tests will examine visual memory pattern, recognition memory, test comprehension, rule acquisition, and attention set shifting. These tests will be administered on a Windows tablet by trained research staff. The participants will start by taking a practice test to get use to using the tablet and test format.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT protein powder supplement
- DIETARY_SUPPLEMENT Vitamins/minerals
Study Locations (2)
Missouri
- Washington University School of Medicine - St Louis
Other
- - Atebubu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,041 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2017-07-30 |
| Phase | NA |
What the finished NCT02757508 record still lists
NCT02757508 is an interventional study that assigns participants to a tested intervention. Its 1,041 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (26% lower).
The record links to 1 condition, with School Feeding Programs and Nutrition Supplements appearing as the primary indexed condition, and to 2 interventions - of which protein powder supplement is the first listed.
NCT02757508 reports a single indexed study location in Missouri, Other.
Frequently Asked Questions
What is clinical trial NCT02757508 about?
NCT02757508 is a clinical study titled "Healthy and Affordable Protein Rich Foods for African Market". This study is to gather information on school feeding programs and to measure the effect on linear growth and cognitive performance when providing a high-quality milk protein source or a combination of a high-quality milk protein source and rice proteins as a nutritional supplement to school childre...
What is the current status of trial NCT02757508?
This trial is currently completed. It is a NA study. The enrollment target is 1,041 participants. The study started on 2016-03-01. Estimated completion is 2017-07-30.
What conditions does trial NCT02757508 study?
This clinical trial studies the following conditions: School Feeding Programs and Nutrition Supplements.
What interventions are being tested in trial NCT02757508?
The interventions under investigation include: protein powder supplement (DIETARY_SUPPLEMENT), Vitamins/minerals (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02757508?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02757508 being conducted?
This trial has 2 study locations across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02757508's enrollment target sits among peer trials
1,041 100th of 2000 higher than 1,901 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04685616 · 1,042 participants · Phase 3
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
- NCT05219110 · 1,040 participants · NA
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
- NCT06564948 · 1,040 participants · NA
Treatment for Individuals Interacting with the Criminal Justice System
- NCT06661720 · 1,040 participants · Phase 3
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI